Advanced Search

Study Preview



Study Title and Description

Ledipasvir/sofosbuvir for treatment-naive and treatment-experienced Chinese patients with genotype 1 HCV: an open-label, phase 3b study.



Key Questions Addressed
6 Key Question 6. What is the effectiveness of currently recommended antiviral treatments in improving health outcomes in patients with HCV infection?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Ledipasvir/sofosbuvir for treatment-naive and treatment-experienced Chinese patients with genotype 1 HCV: an open-label, phase 3b study.
Author Wei L., Xie Q., Hou JL., Tang H., Ning Q., Cheng J., Nan Y., Zhang L., Li J., Jiang J., McNabb B., Zhang F., Camus G., Mo H., Osinusi A., Brainard DM., Gong G., Mou Z., Wu S., Wang G., Hu P., Gao Y., Jia J., Duan Z.
Country Beijing Key Lab for Hepatitis C and Immunologic Liver Disease, Peking University Hepatology Institute, Peking University People's Hospital, 11 Xizhimen S St, Xicheng District, Beijing, 100044, China. weilai@pkuph.edu.cn.
Year 2018
Numbers Pubmed ID: 29637511

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Key Questions 1-9


Results & Comparisons

No Results found.